VRCA·92511W207·US·equity·Healthcare - Biotechnology-Activist
VRCA (VERRICA PHARMACEUTICALS INC) is held by 19 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($743,229), GEODE CAPITAL MANAGEMENT, LLC ($734,965), Squarepoint Ops LLC ($397,850). Net institutional sentiment: Mixed.
See how VRCA's score breaks down across 4 SEC sources
Showing 1-20 of 31
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer